2 Growth Stocks with All-Star Potential and 1 We Brush Off
Growth boosts valuation multiples, but it doesn’t always last forever. Companies that cannot maintain it are often penalized with large declines in market value, a lesson ingrained in investors who lost money in tech stocks during 2022.
The risks that can come from buying these assets is precisely why we started StockStory - to isolate the long-term winners from the losers so you can invest with confidence. That said, here are two growth stocks expanding their competitive advantages and one climbing an uphill battle.
One Growth Stock to Sell:
WesBanco (WSBC)
One-Year Revenue Growth: +61.2%
Tracing its roots back to 1870 in West Virginia, WesBanco (NASDAQ:WSBC) is a bank holding company that provides retail and commercial banking, trust services, insurance, and investment products through its subsidiaries across several Midwestern and Mid-Atlantic states.
Why Is WSBC Not Exciting?
- Estimated net interest income growth of 1.9% for the next 12 months implies demand will slow from its five-year trend
- Net interest margin of 3.3% reflects its high servicing and capital costs
- Flat tangible book value per share over the last five years suggest it must find different ways to enhance shareholder value during this cycle
WesBanco’s stock price of $32.90 implies a valuation ratio of 0.8x forward P/B. If you’re considering WSBC for your portfolio, see our FREE research report to learn more.
Two Growth Stocks to Watch:
TTM Technologies (TTMI)
One-Year Revenue Growth: +19%
As one of the world's largest printed circuit board manufacturers with facilities spanning North America and Asia, TTM Technologies (NASDAQ:TTMI) manufactures printed circuit boards (PCBs) and radio frequency (RF) components for aerospace, defense, automotive, and telecommunications industries.
Why Does TTMI Catch Our Eye?
- Annual revenue growth of 14.1% over the last two years was superb and indicates its market share increased during this cycle
- Market share is on track to rise over the next 12 months as its 17.4% projected revenue growth implies demand will accelerate from its two-year trend
- Earnings per share have massively outperformed its peers over the last two years, increasing by 35.2% annually
TTM Technologies is trading at $95.77 per share, or 30x forward P/E. Is now the right time to buy? Find out in our full research report, it’s free.
BrightSpring Health Services (BTSG)
One-Year Revenue Growth: +20.8%
Founded in 1974, BrightSpring Health Services (NASDAQ:BTSG) offers home health care, hospice, neuro-rehabilitation, and pharmacy services.
Why Is BTSG Interesting?
- Annual revenue growth of 20.9% over the past two years was outstanding, reflecting market share gains this cycle
- Economies of scale give it some operating leverage when demand rises
- Forecasted revenue growth of 14.9% for the next 12 months indicates its momentum over the last two years is sustainable
At $41.07 per share, BrightSpring Health Services trades at 26.8x forward P/E. Is now a good time to buy? See for yourself in our in-depth research report, it’s free.
High-Quality Stocks for All Market Conditions
ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.
Find out which 5 stocks it's flagging for this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.
